Codexis to Hold Second Quarter 2020 Conference Call on August 6
Codexis, Inc. (NASDAQ: CDXS) will report its second quarter 2020 financial results on August 6, 2020, after the market closes. The management team will host a conference call at 4:30 p.m. ET to discuss these results and provide an update on the company. Participants can pre-register for the call to receive a passcode for immediate access. A live webcast will also be available on the Codexis investor relations website, with an archive accessible for 90 days. For those unable to attend live, a replay will be available for 48 hours following the call.
- Scheduled financial results announcement for Q2 2020 indicates transparency and communication with investors.
- A dedicated conference call for investors shows commitment to stakeholder engagement.
- None.
REDWOOD CITY, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report second quarter 2020 financial results after market close on Thursday, August 6, 2020. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.
We encourage participants to pre-register for the conference call using the following link: http://dpregister.com/10146500. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Those without internet access or unable to pre-register may dial in by calling:
| U.S. | 866-777-2509 |
| International | 412-317-5413 |
| Passcode | 10146500 |
A live webcast of the call will be available at Codexis IR Website. The webcast will be archived for 90 days.
A replay of the call will be available for 48 hours by calling:
| U.S. | 877-344-7529 |
| Canada | 855-669-9658 |
| International | 412-317-0088 |
| Passcode | 10146500 |
| The replay will be available for 48 hours | |
About Codexis, Inc.
Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to discover, develop and commercialize proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals, industrial enzymes, enzymes for use in molecular biology, diagnostics and other life science applications, and enzymes and other proteins as biotherapeutics. Codexis’ proven technology platform delivers value by enabling highly targeted and application-relevant improvements in protein performance. For more information, see www.codexis.com.
Contact:
LHA Investor Relations
Jody Cain, 310-691-7100
jcain@lhai.com
FAQ
When will Codexis report its second quarter 2020 financial results?
What time is the Codexis conference call for financial results?
How can I join the Codexis conference call?
Will there be a replay available for the Codexis conference call?
